Pushkal Garg - Feb 13, 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg
Stock symbol
ALNY
Transactions as of
Feb 13, 2025
Transactions value $
-$787,904
Form type
4
Date filed
2/18/2025, 04:47 PM
Previous filing
Jan 29, 2025
Next filing
Mar 3, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +3.11K +25.93% $0.00 15.1K Feb 13, 2025 Direct F1
transaction ALNY Common Stock Sale -$88.1K -349 -2.31% $252.50 14.7K Feb 14, 2025 Direct F2, F3
transaction ALNY Common Stock Sale -$97.8K -386 -2.62% $253.37 14.4K Feb 14, 2025 Direct F2, F4
transaction ALNY Common Stock Sale -$65.6K -258 -1.8% $254.35 14.1K Feb 14, 2025 Direct F2, F5
transaction ALNY Common Stock Sale -$28.1K -110 -0.78% $255.56 14K Feb 14, 2025 Direct F2, F6
transaction ALNY Common Stock Sale -$32.3K -126 -0.9% $256.29 13.9K Feb 14, 2025 Direct F2, F7
transaction ALNY Common Stock Sale -$15.5K -60 -0.43% $257.51 13.8K Feb 14, 2025 Direct F2, F8
transaction ALNY Common Stock Sale -$19.9K -77 -0.56% $258.07 13.7K Feb 14, 2025 Direct F2, F9
transaction ALNY Common Stock Sale -$7.01K -27 -0.2% $259.72 13.7K Feb 14, 2025 Direct F2, F10
transaction ALNY Common Stock Sale -$12.8K -49 -0.36% $260.57 13.7K Feb 14, 2025 Direct F2, F11
transaction ALNY Common Stock Sale -$15.7K -60 -0.44% $261.45 13.6K Feb 14, 2025 Direct F2, F12
transaction ALNY Common Stock Sale -$7.11K -27 -0.2% $263.33 13.6K Feb 14, 2025 Direct F2
transaction ALNY Common Stock Sale -$8.48K -32 -0.24% $264.87 13.5K Feb 14, 2025 Direct F2
transaction ALNY Common Stock Sale -$216K -862 -6.37% $250.11 12.7K Feb 18, 2025 Direct F13, F14
transaction ALNY Common Stock Sale -$76.7K -306 -2.41% $250.73 12.4K Feb 18, 2025 Direct F13, F15
transaction ALNY Common Stock Sale -$27.7K -110 -0.89% $251.60 12.3K Feb 18, 2025 Direct F13
transaction ALNY Common Stock Sale -$21.3K -83 -0.68% $256.05 12.2K Feb 18, 2025 Direct F13, F16
transaction ALNY Common Stock Sale -$27.6K -107 -0.88% $257.99 12.1K Feb 18, 2025 Direct F13, F17
transaction ALNY Common Stock Sale -$20.7K -80 -0.66% $259.10 12K Feb 18, 2025 Direct F13
holding ALNY Common Stock 431 Feb 13, 2025 by Managed Account F18
holding ALNY Common Stock 250 Feb 13, 2025 by Trust F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On February 24, 2021, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of four specified performance measures. The shares reported were issued to the reporting person upon vesting of one-quarter of the shares subject to the PSU based on the issuer publicly reporting achievement, on or before December 31, 2025, of non-GAAP operating income profitability for a 12-month calendar year, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on February 13, 2025.
F2 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $251.89 to $252.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $252.90 to $253.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $253.96 to $254.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $254.99 to $255.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.01 to $256.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.05 to $257.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.86 to $258.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.21 to $260.14. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $260.31 to $260.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.42 to $261.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.
F14 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $249.56 to $250.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F15 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $250.57 to $251.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F16 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.00 to $256.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F17 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.79 to $258.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F18 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F19 Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.